1. |
沈宏亮, 王強. 海水浸泡創傷病理生理變化和救治措施的研究進展. 第二軍醫大學學報, 2003, 24: 1365-1367.
|
2. |
虞積耀, 賴西南, 李輝, 等. 戰傷合并海水浸泡生存時間及死亡率的動物實驗研究. 解放軍醫學雜志, 2005, 30: 268-269.
|
3. |
Ferrara N. Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res, 2000, 55: 15-35.
|
4. |
Thickett DR, Armstrong L, and Millar AB. A role for vascular endothelial growth factor in acute and resolving lung injury. Am J Respir Crit Care Med, 2002 , 166: 1332 -1337 .
|
5. |
Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med, 2003, 9: 669-676.
|
6. |
Tsokos M, Pufe T, Paulsen F, et al. Pulmonary expression of vascular endothelial growth factor in sepsis. Arch Pathol Lab Med, 2003, 127: 331-335.
|
7. |
姜曉暉, 王雪芬, 周永列, 等. 急性肺損傷早期支氣管肺泡灌洗液中VEGF 變化的研究. 浙江醫學, 2005, 27: 659-661.
|
8. |
孟激光, 段蘊鈾, 薛志強, 等. 胸部開放傷后海水灌入胸腔致急性肺損傷犬模型的實驗研究. 中華航海醫學與高氣壓醫學雜志, 2008, 15: 74-77.
|
9. |
Koyama S, Sato E, Haniuda M, et al. Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis. Am J Respir Crit Care Med, 2002, 166: 382-385.
|
10. |
Kaner RJ, Crystal RG. Compartmentalization of vascular endothelial growth factor to the epithelial surface of the human lung. Mol Med, 2001, 7: 240-246.
|
11. |
Partovian C, Adnot S, Eddahibi S, et al. Heart and lung VEGF mRNA expression in rate with monocrotaline or hypoxia-induced pulmonary hypertension. Am J Physiol, 1998, 275: H1948-H1956.
|
12. |
Thickett DR, Armstrong L, Christie SJ, et al. Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. Am J Respir Crit Care Med, 2001, 164: 1601-1605.
|
13. |
Maitre B, Boussat S, Jean D, et al. Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury. Eur Respir J, 2001, 18: 100-106.
|
14. |
Kaner RJ, Ladetto JV, Singh R, et al. Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am J Respir Cell Mol Biol, 2000, 22: 657-664.
|
15. |
Mura M, dos Santos CC, Stewart D, et al. Vascular endothelial growth factor and related molecules in acute lung injury. J Appl Physiol, 2004, 97: 1605-1617.
|
16. |
Fehrenbach A, Pufe T, Wittwer T, et al. Reduced vascular endothelial growth factor correlates with alveolar epithelial damage after experimental ischemia and reperfusion. J Heart Lung Transplant, 2003, 22: 967-978.
|
17. |
Koehne P, Willam C, Strauss E, et, al. Lack of hypoxic stimulation of VEGF secretion from neutrophils and platelets. Am J Physiol Heart Circ Physiol, 2000, 279: H817-H824.
|
18. |
Haddad el-B, McCluskie K, Birrell MA, et al. Differential effects of ebselen on neutrophil recruitment, chemokine, and inflammatory mediator expression in a rat model of lipopolysaccharide-induced pulmonary inflammation. J Immunol, 2002, 169: 974-982.
|
19. |
Mukaida N. Pathophysiological roles of interleukin-8 / CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol, 2003 , 284: L566-L577.
|
20. |
Shames BD, Zallen GS, McIntyre RC Jr, et al. Chemokines as mediators of diseases related to surgical conditions. Shock, 2000,14: 1.
|
21. |
Riffo-Vasquez Y, Spina D. Role of cytokines and chemokines in bronchial hyperresponsiveness and airway inflammation. Pharmacol Ther, 2002, 94: 185-211.
|
22. |
Varol E, Ozaydin M, Sahin M, et al. vWf levels as a circulating marker of endothelial dysfunction in patients with hypertrophic cardiomyopathy. Indian Heart J, 2005, 57: 655-657.
|